The Medicines Company to Host Cangrelor Webcast on Sunday, March 10, 2013

Conference Call to Be Held at 11:00 a.m. Pacific Time

(firmenpresse) - PARSIPPANY, NJ -- (Marketwire) -- 03/08/13 -- The Medicines Company (NASDAQ: MDCO) has scheduled a conference call and webcast following release of the Phase 3 cangrelor CHAMPION PHOENIX trial results on Sunday, March 10, 2013 at 11:00 a.m. Pacific Time, 2:00 p.m. Eastern Time. MDCO management and experts are scheduled to discuss cangrelor trial results and outlook.

The conference call will be available via phone and webcast. The dial in information is listed below:

Domestic Dial In: 866 700.6067
International Dial In: 617 213.8834
Passcode for both dial in numbers: 54431050

Replay is available from 4:00 p.m. Eastern Time following the conference call through March 17, 2013. To hear a replay of the call, dial 888 286.8010 (domestic) and 617 801.6888 (international). Passcode for both dial in numbers is 17733784.

This call is being webcast and can be accessed at The Medicines Company website at .

The Medicines Company (NASDAQ: MDCO) provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients. The Medicines Company's website is .





Contact:
Michael Mitchell
The Medicines Company
973-290-6097

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 08.03.2013 - 15:22 Uhr
Sprache: Deutsch
News-ID 237566
Anzahl Zeichen: 0

contact information:
Town:

PARSIPPANY, NJ

Kategorie:

Healthcare

Diese Pressemitteilung wurde bisher 184 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"The Medicines Company to Host Cangrelor Webcast on Sunday, March 10, 2013"
steht unter der journalistisch-redaktionellen Verantwortung von

The Medicines Company (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

The Medicines Company to Participate in Upcoming Investor Conference Webcasts ...

PARSIPPANY, NJ -- (Marketwired) -- 11/27/13 -- The Medicines Company (NASDAQ: MDCO) is scheduled to present at the 25th Annual Piper Jaffray Healthcare Conference on December 4th at 12:30 PM Eastern Time. MDCO is also scheduled to present at the Opp ...

European Medicines Agency Accepts Marketing Authorization Application for The Me ...

PARSIPPANY, NJ -- (Marketwired) -- 11/21/13 -- The Medicines Company (NASDAQ: MDCO) today announced that the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for the investigational hemostatic agent ...

FDA Grants QIDP Designation to The Medicines Company's Investigational Anti ...

PARSIPPANY, NJ -- (Marketwired) -- 11/12/13 -- The Medicines Company (NASDAQ: MDCO) today announced that the U.S. Food and Drug Administration (FDA) has designated oritavancin as a Qualified Infectious Disease Product (QIDP). The QIDP designation pr ...

Alle Meldungen von The Medicines Company